Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Smart algorithms already detect changes such as short and long-term changes in resting heart rates – an indicator of overall ...

Arkansas Gov. Sarah Huckabee Sanders announced the "Healthy Moms, Healthy Babies Act," a multi-million dollar initiative ...

Amdist a backdrop of moms with babies, Gov. Sarah Sanders Thursday (Feb. 6) unveiled at the state capitol her much ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq ...